Cart
sales@molnova.com
Ursodeoxycholic acid
CAS No. 128-13-2
Ursodeoxycholic acid ( —— )
Catalog No. M11156 CAS No. 128-13-2
Ursodiol reduces cholesterol absorption and is used to dissolve gallstones.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1G | 45 | In Stock |
|
Biological Information
-
Product NameUrsodeoxycholic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionUrsodiol reduces cholesterol absorption and is used to dissolve gallstones.
-
DescriptionUrsodiol reduces cholesterol absorption and is used to dissolve gallstones.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorBile salt export pump
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number128-13-2
-
Formula Weight392.57
-
Molecular FormulaC24H40O4
-
Purity>98%(HPLC)
-
SolubilityEthanol: 79 mg/mL (201.23 mM); DMSO: 79 mg/mL (201.23 mM)
-
SMILESC[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schuetz EG, et al. J Biol Chem. 2001 Oct 19;276(42):39411-8.
molnova catalog
related products
-
NS 1619
NS1619 have been reported to have cardio-protective effects after ischemic-reperfusion injury.
-
KCNQ1 activator-1?
2-Piperidinecarboxamide, N-[4-(4-methoxyphenyl)-2-thiazolyl]-1-(phenylsulfonyl)- is a potent KCNQ1 channel activator that can be used in long QT syndrome (LQTS) studies.
-
Margatoxin
Potent KV1.3 channel blocker (IC50 = 36 pM). Displays no effect at calcium-activated channels. Reduces VEGF-induced transmembrane calcium influxes and nitric oxide production in human endothelial cells.
